- Targeting liver cancer stem cells for the treatment of hepatocellular carcinoma
Na Li et al, 2019, Therapeutic Advances in Gastroenterology CrossRef - Casticin inhibits stemness of hepatocellular carcinoma cells via disrupting the reciprocal negative regulation between DNMT1 and miR-148a-3p
Xiang Li et al, 2020, Toxicology and Applied Pharmacology CrossRef - Twist in hepatocellular carcinoma: pathophysiology and therapeutics
Hui Zou et al, 2015, Hepatology International CrossRef - RETRACTED ARTICLE: Casticin inhibits epithelial-mesenchymal transition of EBV-infected human retina pigmental epithelial cells through the modulation of intracellular lipogenesis
Ga Bin Park et al, 2017, Graefe's Archive for Clinical and Experimental Ophthalmology CrossRef - Casticin inhibits interleukin-1β-induced ICAM-1 and MUC5AC expression by blocking NF-κB, PI3K-Akt, and MAPK signaling in human lung epithelial cells
Chian-Jiun Liou et al, 2017, Oncotarget CrossRef - 7-Difluoromethoxyl-5,4′-di-n-octyl genistein inhibits the stem-like characteristics of gastric cancer stem-like cells and reverses the phenotype of epithelial-mesenchymal transition in gastric cancer cells
Xiaozheng Cao et al, 2016, Oncology Reports CrossRef - Casticin attenuates liver fibrosis and hepatic stellate cell activation by blocking TGF-β/Smad signaling pathway
Ling Zhou et al, 2017, Oncotarget CrossRef - Casticin Attenuates Stemness in Cervical Cancer Stem-Like Cells by Regulating Activity and Expression of DNMT1
Xue-li Wang et al, 2023, Chinese Journal of Integrative Medicine CrossRef - Casticin from Vitex species: a short review on its anticancer and anti-inflammatory properties
Eric Wei Chiang Chan et al, 2018, Journal of Integrative Medicine CrossRef - Casticin inhibits the epithelial-mesenchymal transition in ovarian carcinoma via the hedgehog signaling pathway
Jing Zhang et al, 2018, Oncology Letters CrossRef - An Overview of the Potential Antineoplastic Effects of Casticin
Shanaya Ramchandani et al, 2020, Molecules CrossRef - Casticin inhibits invasion and proliferation via downregulation of β‐catenin and reversion of EMT in oral squamous cell carcinoma
Yaxin Xie et al, 2019, Journal of Oral Pathology & Medicine CrossRef